News for Healthier Living

Clinical Trial Shows Positive Results of Enhanced CAR T-Cell Therapy for Patients with B-Cell Blood Cancers

* Results from a phase I clinical trial show enhanced chimeric antigen receptor (CAR) T-cell therapy improved outcomes for patients with B-cell blood cancers. * Building on their previous work, researchers tested targeting three proteins and used another protein to boost immune response in patients. * Data showed better outcomes for patients who have limited options after their B-cell blood cancer returned or previous therapy stopped working.

October 13, 2026


October 17 2026

October 16 2026

October 15 2026

October 14 2026

October 13 2026

October 12 2026

October 11 2026

October 10 2026

October 9 2026

October 8 2026

October 7 2026

October 6 2026

October 5 2026